| Value | ₹10.00 Cr |
|---|
BSE filing, NSE: TRABI. Summary written from the filing by ALFA Finder's alert engine.
Transgene Biotek Ltd: key numbers
- Share price
- ₹2.40
- Market cap
- ₹18.18 Cr
- Revenue (annual)
- ₹0.21 Cr
- Net profit (annual)
- ₹-1.65 Cr
- P/E (TTM)
- -11.3×Sector 53.8×
- Promoter holding
- 23.64%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Transgene Biotek Ltd
All →Transgene Biotek Other Announcement
Transgene Biotech appointed M/s. Harish Gummadi & Co as Statutory Auditor for a two-month term effective 2 November 2026. The appointment was approved at the board meeting on the same date.
- Execution
- 2 months
Transgene Biotek Management Change
Transgene Biotek's statutory auditors Eswara Rao & Co. resigned effective 28 October 2026 citing pre-occupation. The company will appoint new auditors per applicable regulations.
Transgene Biotek Board Meeting Outcome
Transgene Biotek Limited appointed M/s. Eswara Rao & Co. as the new statutory auditor to fill a casual vacancy, subject to shareholder approval.
Transgene Biotek Other Announcement
The company filed a Regulation 74(5) certificate from its Registrar, confirming dematerialization activities for the quarter ended September 30, 2026.
Transgene Biotek Board Meeting Date
Transgene Biotek Ltd has scheduled a board meeting for October 10, 2026, to consider appointing a new statutory auditor to fill a casual vacancy.
Transgene Biotek Annual General Meeting
Transgene Biotek has received ROC approval to extend its 36th AGM deadline by three months. The meeting for FY2025-26 will now be held by December 31, 2026.
Other capital structure change announcements
All →Bharti Airtel Capital Structure Change
Bharti Airtel issued a Second Reminder Notice for payment of First and Final Call of INR 401.25 per partly paid-up share plus 10% interest. Payment window runs November 5 to 19, 2026, for 649,835 outstanding shares.
- Value
- ₹26.07 Cr
- Execution
- November 5, 2026 to November 19, 2026
Acetech E-Commerce Capital Structure Change
Acetech E-Commerce submitted a Draft Letter of Offer for a proposed Rights Issue of equity shares up to Rs. 4000 Lakhs. The filing is a preliminary rights-issue step with issue price and ratio still blank.
- Value
- ₹40.00 Cr
Indrayani Biotech Capital Structure Change
Indrayani Biotech allotted 83,64,036 rights equity shares at Rs 15 (75,03,333 fully paid) and Rs 3.75 (8,60,703 partly paid). Issue receipts total about Rs 11.58 Crore.
- Value
- ₹11.58 Cr
Shlokka Dyes Capital Structure Change
Shlokka Dyes proposed raising its authorised capital to 2.9 crore shares, pending approval at a 28 November 2026 meeting. No fresh capital has been raised yet.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ received BSE in-principle approval for its Rights Issue and has convened a board meeting on 4 November 2026 to fix the issue price and record date. The issue was earlier approved for up to Rs 40 Crore.
DCW Capital Structure Change
DCW Ltd bought back 155,000 equity shares on NSE on 03-Nov-2026 at an average price of Rs.45.18. The daily report puts the day's buyback spend at about Rs.0.70 Crore.
- Value
- ₹0.70 Cr